Infertility Treatment Market by Product, Procedure, Patient type, End User

List of Tables

The Infertility Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.93 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 11.30 billion by 2030.

The infertility treatment market encompasses a range of therapeutic approaches aimed at aiding individuals and couples unable to conceive naturally. These treatments include assisted reproductive technologies (ART) like in vitro fertilization (IVF), fertility drugs, surgeries, and other interventions. The necessity for infertility treatments arises from the growing number of individuals facing fertility challenges due to lifestyle factors, health conditions, and delayed childbearing. The end-use scope primarily includes fertility clinics, hospitals, and surgical centers, with an increasing number of services also being offered through specialized fertility centers. Key growth factors for this market include technological advancements in ART, increased funding and insurance coverage for infertility treatments, and growing awareness regarding fertility preservation. However, certain limitations and challenges remain, such as the high costs associated with treatments, cultural and social stigmas, and varying regulatory landscapes across regions.

KEY MARKET STATISTICS
Base Year [2023]	USD 5.35 billion
Estimated Year [2024]	USD 5.93 billion
Forecast Year [2030]	USD 11.30 billion
CAGR (%)	11.26%

Latest potential opportunities lie in the development of more cost-effective and minimally invasive treatment options, largely driven by innovation in diagnostic tools and personalized medicine approaches. Additionally, emerging markets present significant opportunities, given the increasing disposable income and changing demographics. Recommendations for stakeholders include investing in research to improve success rates of treatments and reduce side-effects, enhancing accessibility through partnerships with healthcare providers, and engaging in customer education initiatives to destigmatize infertility issues. Limitations such as stringent regulatory requirements and ethical concerns related to ART can slow down market growth. Despite these challenges, the market offers areas of innovation, particularly in genetic screening and embryo selection technologies, which can increase success rates and refine personalization in treatments. The market is evolving towards an integrated care approach, combining medical treatments with supportive services like counseling and nutritional guidance, offering a holistic solution that is gaining favor in consumer preferences.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infertility Treatment Market

The Infertility Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising number of infrastructure projects all over the world
- Potential demand for electrical conduit owing to reliability and durability
- Rapid extension of smart grid networks
Market Restraints
- Concern associated with raw material voltality
Market Opportunities
- Proliferation of electricity usage attributed to digitalization
- Ongoing refurbishment and retrofit activities in grid infrastructure
Market Challenges
- Difficulty in installation process coupled with hard to find defects in wiring

Porter's Five Forces: A Strategic Tool for Navigating the Infertility Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infertility Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infertility Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infertility Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infertility Treatment Market

A detailed market share analysis in the Infertility Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infertility Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infertility Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infertility Treatment Market

A strategic analysis of the Infertility Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Limited, Aliaxis Group S.A., ANAMET Electrical, Inc., Astral PolyTechnik Limited, Atkore International Holdings Incorporated, Cantex, Inc., China Lesso Group Holdings Ltd., Dura-line Corporation, Electri-Flex Company, Hellermanntyton group plc, Hubbell Incorporated, Legrand S.A., Nan Ya Plastics Corp., National pipe & plastics, Inc., Orbia Advance Corporation, Schneider Electric SE, Sekisui Chemical Co., Ltd., Thomas & Betts Corporation, Wienerberger AG, and Zekelman Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Infertility Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices.
Based on Procedure, market is studied across Artificial Insemination, Assisted Reproductive Technology, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology is further studied across In Vitro Fertilization, Intracytoplasmic Sperm Injection, and Surrogacy. The In Vitro Fertilization is further studied across Gamete Donation and Intracytoplasmic Morphologically Selected Sperm Injection. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Laparotomy, Microsurgical Reconstruction, Myomectomy, Tubal Ligation Reversal, and Varicocelectomy. The Microsurgical Reconstruction is further studied across Vasoepididymostomy and Vasovasostomy.
Based on Patient type, market is studied across Female Infertility Treatment and Male Infertility Treatment.
Based on End User, market is studied across Cryobanks, Fertility Centers, Hospitals & Surgical Clinics, and Research Institutes.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-3E32260F8122

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising number of infrastructure projects all over the world
  - 5.1.1.2. Potential demand for electrical conduit owing to reliability and durability
  - 5.1.1.3. Rapid extension of smart grid networks
- 5.1.2. Restraints
  - 5.1.2.1. Concern associated with raw material voltality
- 5.1.3. Opportunities
  - 5.1.3.1. Proliferation of electricity usage attributed to digitalization
  - 5.1.3.2. Ongoing refurbishment and retrofit activities in grid infrastructure
- 5.1.4. Challenges
  - 5.1.4.1. Difficulty in installation process coupled with hard to find defects in wiring
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Infertility Treatment Market, by Product

6.1. Introduction
6.2. Accessories
6.3. Equipment
- 6.3.1. Cryosystems
- 6.3.2. Gas Analyzers
- 6.3.3. Imaging Systems
- 6.3.4. Incubators
- 6.3.5. Laser Systems
- 6.3.6. Micromanipulator Systems
- 6.3.7. Microscopes
- 6.3.8. Ovum Aspiration Pumps
- 6.3.9. Sperm Analyzer Systems
- 6.3.10. Sperm Separation Devices
6.4. Media & Consumables

7. Infertility Treatment Market, by Procedure

7.1. Introduction
7.2. Artificial Insemination
- 7.2.1. Intracervical Insemination
- 7.2.2. Intratubal Insemination
- 7.2.3. Intrauterine Insemination
7.3. Assisted Reproductive Technology
- 7.3.1. In Vitro Fertilization
  - 7.3.1.1. Gamete Donation
  - 7.3.1.2. Intracytoplasmic Morphologically Selected Sperm Injection
- 7.3.2. Intracytoplasmic Sperm Injection
- 7.3.3. Surrogacy
7.4. Fertility Surgeries
- 7.4.1. Hysteroscopy
- 7.4.2. Laparoscopy
- 7.4.3. Laparotomy
- 7.4.4. Microsurgical Reconstruction
  - 7.4.4.1. Vasoepididymostomy
  - 7.4.4.2. Vasovasostomy
- 7.4.5. Myomectomy
- 7.4.6. Tubal Ligation Reversal
- 7.4.7. Varicocelectomy

8. Infertility Treatment Market, by Patient type

8.1. Introduction
8.2. Female Infertility Treatment
8.3. Male Infertility Treatment

9. Infertility Treatment Market, by End User

9.1. Introduction
9.2. Cryobanks
9.3. Fertility Centers
9.4. Hospitals & Surgical Clinics
9.5. Research Institutes

10. Americas Infertility Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Infertility Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. ABB Limited
2. Aliaxis Group S.A.
3. ANAMET Electrical, Inc.
4. Astral PolyTechnik Limited
5. Atkore International Holdings Incorporated
6. Cantex, Inc.
7. China Lesso Group Holdings Ltd.
8. Dura-line Corporation
9. Electri-Flex Company
10. Hellermanntyton group plc
11. Hubbell Incorporated
12. Legrand S.A.
13. Nan Ya Plastics Corp.
14. National pipe & plastics, Inc.
15. Orbia Advance Corporation
16. Schneider Electric SE
17. Sekisui Chemical Co., Ltd.
18. Thomas & Betts Corporation
19. Wienerberger AG
20. Zekelman Industries Inc.